去势抵抗性前列腺癌的临床试验
总计1397个结果
-
Rahul AggarwalMerck Sharp & Dohme LLC; U.S. Army Medical Research and Development Command; Zenith Epigenetics招聘中去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 转移性前列腺癌 | 转移性前列腺小细胞癌美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
University Hospital, Basel, Switzerland尚未招聘
-
Novartis Pharmaceuticals招聘中转移性去势抵抗性前列腺癌 (mCRPC)法国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of Defense招聘中
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
OHSU Knight Cancer InstituteJanssen Scientific Affairs, LLC; Oregon Health and Science University主动,不招人
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer Center主动,不招人
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker 和其他合作者招聘中
-
Bayer终止骨转移 | 转移性去势抵抗性前列腺癌中国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Rana McKay, MDBristol-Myers Squibb; Exelixis招聘中
-
VA Office of Research and DevelopmentMerck Sharp & Dohme LLC招聘中
-
Roswell Park Cancer InstituteActive Biotech AB完全的
-
Novartis Pharmaceuticals主动,不招人
-
Istituto Scientifico Romagnolo per lo Studio e...主动,不招人转移性去势抵抗性前列腺癌 | 68Ga-PSMA PET/CT 阳性意大利
-
Jonsson Comprehensive Cancer CenterNovartis; Stand Up To Cancer; Prostate Cancer Foundation主动,不招人
-
Turku University Hospital招聘中
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer Center完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人
-
Bayer完全的
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Astex Pharmaceuticals, Inc.; Institute of Cancer Research, United Kingdom招聘中
-
National Cancer Institute (NCI)终止
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Prostate Cancer Foundation; Madison Vaccines, Inc主动,不招人
-
pharmaand GmbHFoundation Medicine主动,不招人转移性去势抵抗性前列腺癌美国, 加拿大, 西班牙, 法国, 澳大利亚, 爱尔兰, 比利时, 丹麦, 英国, 德国, 以色列, 意大利
-
zr Pharma & GmbHFoundation Medicine完全的转移性去势抵抗性前列腺癌美国, 西班牙, 英国, 法国, 澳大利亚, 比利时, 丹麦, 以色列, 德国, 爱尔兰, 加拿大, 意大利
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni Foundation终止
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.终止
-
National University Hospital, SingaporeNational University of Singapore主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI)招聘中
-
Amgen完全的
-
Blue Earth Therapeutics LtdPSI CRO招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人转移性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 去势敏感性前列腺癌美国
-
Stanford UniversityNational Cancer Institute (NCI)终止
-
M.D. Anderson Cancer CenterJanssen Pharmaceutica主动,不招人去势抵抗性前列腺癌 | 转移性前列腺癌 | IV 期前列腺癌 AJCC v8 | 侵袭性变异型前列腺癌 | 转移性前列腺神经内分泌癌 | 转移性前列腺小细胞癌美国
-
Hansoh BioMedical R&D Company招聘中
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.完全的转移性去势抵抗性前列腺癌 (mCRPC)法国, 德国, 西班牙, 美国, 阿根廷, 澳大利亚, 比利时, 加拿大, 智利, 捷克语, 芬兰, 匈牙利, 以色列, 意大利, 大韩民国, 新西兰, 新加坡, 瑞典, 台湾, 英国
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.招聘中
-
Regeneron Pharmaceuticals招聘中转移性去势抵抗性前列腺癌 (mCRPC) | 透明细胞肾细胞癌 (ccRCC)美国